+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary CRO Market by Services Type, Animal Type, and Indication: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 231 Pages
  • October 2021
  • Region: Global
  • Allied Market Research
  • ID: 5237500
The global veterinary CRO market was valued at $577.20 in 2020 and is projected to reach $1,175.72 by 2030 registering a CAGR of 7.7% from 2021 to 2030.

Contract research organizations (CROs) are companies that assist in research & development and/or other services related to newer products for sponsor companies. Sponsors frequently outsource their product development functions to independent service providers to augment their practice of a flexible cost structure and overcome the requirement to maintain redundant development proficiencies globally. Clinical, regulatory, and therapeutic expertise of CROs help improvise total cost of product development and market entry of a new product.

As a result, CROs have emerged as competent providers of an increasing array of value-added services for veterinary companies and are expected to continue to play a vital role in the in vivo studies involving companion animals. Furthermore, veterinary CROs support sponsor companies by providing assistance in veterinary clinical trial development, strategic regulatory affairs expertise, project management support for an extensive range of veterinary products, new product development, lifecycle management of existing marketing authorizations (MA), and veterinary good clinical practice (GCP) regulatory management.

Veterinary CROs also offer services such as strategic advice on data management & statistical analysis, post-marketing support, gap analysis, as well as pharmacovigilance. These services are often used by veterinary researchers and medicine manufacturers for newer product development along with testing safety & efficacy of veterinary drugs.

The growth rate is majorly attributed to surge in ownership of companion animals and rise in animal health expenditure. This, in turn is expected to increase the demand of novel veterinary treatments which in turn is expected to increase outsourcing, thereby driving the growth of the veterinary CRO market. Furthermore, other factors such as increase in global prevalence of diseases among companion animals which again lead to surge in demand for new therapeutics fuel the growth of the market. Furthermore, factors such as surge in the R&D activities among veterinary medicine manufacturers act as key development factors that contribute toward growth in need for outsourcing the process thereby driving the growth of the market.

Nevertheless, lack of standardization in veterinary CROs is anticipated to hinder the market growth. Conversely, awareness associated with animal healthcare is on the rise as pet owners are concerned about health and diseases of their companion animals. This increase in awareness related to animal healthcare across the globe is expected to provide profitable opportunities for key industry players in the market during the forecast period. Furthermore, presence of associations and NGOs that work toward spreading awareness related to animal healthcare are predicted to expose newer possibilities for the growth of veterinary CROs market. On the other hand, COVID-19 pandemic has greatly disrupted ongoing activities in the veterinary sector. Cost constraints on the entire animal healthcare industry, owing to economic slowdown due to the pandemic has imposed limitations on R&D finances of veterinary companies and has led companies to outsource these activities to veterinary CROs, consequently supplementing the market growth.

Moreover, susceptibility of domesticated animals to SARS-CoV-2 along with reported cases in cats and dogs have raised concerns regarding infection to emerge as a disease in animals in the coming years. Accordingly, there is a substantial increase in R&D activities for the development of COVID-19 veterinary vaccines and antiviral drugs. This has immensely increased the demand for companion animals such as cats for research purposes. Several clinical trials around the globe are currently investigated, which drives the demand for such animals.

The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, it is classified into dogs, and cats. Depending on indication, it is categorized into dermatology, gastrointestinal, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA

Major key players operating in veterinary CRO market include Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd., VetPharm, Inc. and VETSPIN SRL

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Services Type

  • Clinical Trials
  • Toxicology
  • Market Authorization & Regulatory Support
  • Others

By Animals Type

  • Dogs
  • Cats

By Indication

  • Dermatology
  • Gastrointestinal
  • Others

KEY MARKET PLAYERS

  • Charles River Laboratories, Inc.
  • Clinvet
  • KLIFOVET AG
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd.
  • VetPharm, Inc.
  • VETSPIN SRL
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • InVentiv
  • INC Research
  • LabCrop.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.1.1. Top impacting factors
3.1.2. Top investment pockets
3.2. Key forces shaping veterinary CRO industry/ market
3.2.1. Bargaining power of buyers
3.2.2. Bargaining power of suppliers
3.2.3. Threat of new entrants
3.2.4. Threat of substitutes
3.2.5. Intensity of competitive rivalry
3.3. Top player positioning, 2020
3.4. Top winning strategies
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Surge in ownership of companion animals
3.5.1.2. Rise in animal health expenditure
3.5.1.3. Increase in prevalence of diseases among companion animals
3.5.2. Restraint
3.5.2.1. Lack of standardization in veterinary CROs
3.5.3. Opportunity
3.5.3.1. Surge in awareness related to animal healthcare
3.5.4. Impact Analysis
3.6. COVID-19 Impact analysis on the market
CHAPTER 4: VETERINARY CRO MARKET, BY SERVICE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Clinical trials
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Toxicology
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Market authorization and regulatory support
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: VETERINARY CRO MARKET, BY ANIMAL TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Dogs
5.2.1. Key market trends and growth opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Cats
5.3.1. Key market trends and growth opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: VETERINARY CRO MARKET, BY INDICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Dermatology
6.2.1. Key market trends and growth opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Gastrointestinal
6.3.1. Key market trends and growth opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Others
6.4.1. Key market trends and growth opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: VETERINARY CRO MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. North America market size and forecast, by service type
7.2.4. North America market size and forecast, by animal type
7.2.5. North America market size and forecast, by indication
7.2.5.1. U.S.
7.2.5.1.1. U.S. market size and forecast, by service type
7.2.5.1.2. U.S. market size and forecast, by animal type
7.2.5.1.3. U.S. market size and forecast, by indication
7.2.5.2. Canada
7.2.5.2.1. Canada market size and forecast, by service type
7.2.5.2.2. Canada market size and forecast, by animal type
7.2.5.2.3. Canada market size and forecast, by indication
7.2.5.3. Mexico
7.2.5.3.1. Mexico market size and forecast, by service type
7.2.5.3.2. Mexico market size and forecast, by animal type
7.2.5.3.3. Mexico market size and forecast, by indication
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Europe market size and forecast, by service type
7.3.4. Europe market size and forecast, by animal type
7.3.5. Europe market size and forecast, by indication
7.3.5.1. Germany
7.3.5.1.1. Germany market size and forecast, by service type
7.3.5.1.2. Germany market size and forecast, by animal type
7.3.5.1.3. Germany market size and forecast, by indication
7.3.5.2. France
7.3.5.2.1. France market size and forecast, by service type
7.3.5.2.2. France market size and forecast, by animal type
7.3.5.2.3. France market size and forecast, by indication
7.3.5.3. UK
7.3.5.3.1. UK market size and forecast, by service type
7.3.5.3.2. UK market size and forecast, by animal type
7.3.5.3.3. UK market size and forecast, by indication
7.3.5.4. Italy
7.3.5.4.1. Italy market size and forecast, by service type
7.3.5.4.2. Italy market size and forecast, by animal type
7.3.5.4.3. Italy market size and forecast, by indication
7.3.5.5. Spain
7.3.5.5.1. Spain market size and forecast, by service type
7.3.5.5.2. Spain market size and forecast, by animal type
7.3.5.5.3. Spain market size and forecast, by indication
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe market size and forecast, by service type
7.3.5.6.2. Rest of Europe market size and forecast, by animal type
7.3.5.6.3. Rest of Europe market size and forecast, by indication
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by service type
7.4.4. Asia-Pacific market size and forecast, by animal type
7.4.5. Asia-Pacific market size and forecast, by indication
7.4.5.1. Japan
7.4.5.1.1. Japan market size and forecast, by service type
7.4.5.1.2. Japan market size and forecast, by animal type
7.4.5.1.3. Japan market size and forecast, by indication
7.4.5.2. China
7.4.5.2.1. China market size and forecast, by service type
7.4.5.2.2. China market size and forecast, by animal type
7.4.5.2.3. China market size and forecast, by indication
7.4.5.3. Australia
7.4.5.3.1. Australia market size and forecast, by service type
7.4.5.3.2. Australia market size and forecast, by animal type
7.4.5.3.3. Australia market size and forecast, by indication
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Rest of Asia-Pacific market size and forecast, by service type
7.4.5.4.2. Rest of Asia-Pacific market size and forecast, by animal type
7.4.5.4.3. Rest of Asia-Pacific market size and forecast, by indication
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by country
7.5.3. LAMEA market size and forecast, by service type
7.5.4. LAMEA market size and forecast, by animal type
7.5.5. LAMEA market size and forecast, by indication
7.5.5.1. Brazil
7.5.5.1.1. Brazil market size and forecast, by service type
7.5.5.1.2. Brazil market size and forecast, by animal type
7.5.5.1.3. Brazil market size and forecast, by indication
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia market size and forecast, by service type
7.5.5.2.2. Saudi Arabia market size and forecast, by animal type
7.5.5.2.3. Saudi Arabia market size and forecast, by indication
7.5.5.3. South Africa
7.5.5.3.1. South Africa market size and forecast, by service type
7.5.5.3.2. South Africa market size and forecast, by animal type
7.5.5.3.3. South Africa market size and forecast, by indication
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA market size and forecast, by service type
7.5.5.4.2. Rest of LAMEA market size and forecast, by animal type
7.5.5.4.3. Rest of LAMEA market size and forecast, by indication
CHAPTER 8: COMPANY PROFILES
8.1. CHARLES RIVER LABORATORIES, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Service portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CLINVET
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Service portfolio
8.2.5. Key strategic moves and developments
8.3. KLIFOVET AG
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Service portfolio
8.3.5. Key strategic moves and developments
8.4. LÖHLEIN & WOLF VET RESEARCH
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Service portfolio
8.5. ONCOVET CLINICAL RESEARCH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Service portfolio
8.6. ONDAX SCIENTIFIC
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Service portfolio
8.7. TRIVERITAS
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Service portfolio
8.7.5. Key strategic moves and developments
8.8. VETERINARY RESEARCH MANAGEMENT (VRM) LTD
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Service portfolio
8.9. VETPHARM, INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Service portfolio
8.10. VETSPIN SRL
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Service portfolio
List of Tables
TABLE 01. NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)
TABLE 02. POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2020
TABLE 03. PARASITE DISEASES & THEIR PREVALENCE IN U.S.,2020
TABLE 04. VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 05. VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY REGION, 2020-2030 ($MILLION)
TABLE 07. VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY REGION 2020-2030 ($MILLION)
TABLE 08. VETERINARY CRO MARKET FOR OTHER SERVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 09. VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 10. VETERINARY CRO MARKET FOR DOGS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. VETERINARY CRO MARKET FOR CATS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 13. VETERINARY CRO MARKET FOR DERMATOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 14. VETERINARY CRO MARKET FOR GASTROINTESTINAL, BY REGION, 2020-2030 ($MILLION)
TABLE 15. VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY REGION 2020-2030 ($MILLION)
TABLE 16. VETERINARY CRO MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18. NORTH AMERICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 19. NORTH AMERICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 20. NORTH AMERICA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 21. U.S. VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 22. U.S. VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 23. U.S. VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 24. CANADA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 25. CANADA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 26. CANADA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 27. MEXICO VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 28. MEXICO VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 29. MEXICO VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 30. EUROPE VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 31. EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 32. EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 33. EUROPE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 34. GERMANY VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 35. GERMANY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 36. GERMANY VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 37. FRANCE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 38. FRANCE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 39. FRANCE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 40. UK VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 41. UK VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 42. UK VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 43. ITALY VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 44. ITALY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 45. ITALY VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 46. SPAIN VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 47. SPAIN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 48. SPAIN VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 51. REST OF EUROPE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 55. ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 56. JAPAN VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 57. JAPAN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 58. JAPAN VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 59. CHINA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 60. CHINA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 61. CHINA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 62. AUSTRALIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 63. AUSTRALIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 68. LAMEA VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 69. LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 70. LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 71. LAMEA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 72. BRAZIL VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 73. BRAZIL VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 74. BRAZIL VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 75. SAUDI ARABIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 76. SAUDI ARABIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 77. SAUDI ARABIA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 78. SOUTH AFRICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 79. SOUTH AFRICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 80. SOUTH AFRICA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 81. REST OF LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 82. REST OF LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 83. REST OF LAMEA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 84. CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 85. CHARLES RIVER LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 86. CHARLES RIVER LABORATORIES, INC. PLC: SERVICE PORTFOLIO
TABLE 87. CLINVET: COMPANY SNAPSHOT
TABLE 88. CLINVET INC.: OPERATING SEGMENTS
TABLE 89. CLINVET INC.: SERVICE PORTFOLIO
TABLE 90. KLIFOVET AG: COMPANY SNAPSHOT
TABLE 91. KLIFOVET AG: OPERATING SEGMENTS
TABLE 92. KLIFOVET AG: SERVICE PORTFOLIO:
TABLE 93. LÖHLEIN & WOLF VET RESEARCH: COMPANY SNAPSHOT
TABLE 94. LÖHLEIN & WOLF VET RESEARCH: OPERATING SEGMENTS
TABLE 95. LÖHLEIN & WOLF VET RESEARCH: SERVICE PORTFOLIO
TABLE 96. ONCOVET CLINICAL RESEARCH: COMPANY SNAPSHOT
TABLE 97. ONCOVET CLINICAL RESEARCH: OPERATING SEGMENTS
TABLE 98. ONCOVET CLINICAL RESEARCH: SERVICE PORTFOLIO
TABLE 99. ONDAX SCIENTIFIC: COMPANY SNAPSHOT
TABLE 100. ONDAX SCIENTIFIC: OPERATING SEGMENTS
TABLE 101. ONDAX SCIENTIFIC: SERVICE PORTFOLIO
TABLE 102. TRIVERITAS: COMPANY SNAPSHOT
TABLE 103. TRIVERITAS: OPERATING SEGMENTS
TABLE 104. TRIVERITAS: SERVICE PORTFOLIO
TABLE 105. VRM: COMPANY SNAPSHOT
TABLE 106. VRM: OPERATING SEGMENTS
TABLE 107. VRM: SERVICE PORTFOLIO
TABLE 108. VETPHARM, INC.: COMPANY SNAPSHOT
TABLE 109. VETPHARM, INC.: BUSINESS SEGMENTS
TABLE 110. VETPHARM, INC.: SERVICE PORTFOLIO
TABLE 111. VETSPIN SRL.: COMPANY SNAPSHOT
TABLE 112. VETSPIN SRL.: OPERATING SEGMENTS
TABLE 113. VETSPIN SRL: SERVICE PORTFOLIO
List of Figures
FIGURE 01. VETERINARY CRO MARKET: SEGMENTATION
FIGURE 02. TOP IMPACTING FACTORS
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 08. HIGH COMPETITIVE RIVALRY
FIGURE 09. TOP PLAYER POSITIONING, 2020
FIGURE 10. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2021-2030
FIGURE 11. TOP WINNING STRATEGIES:BY DEVELOPMENT, 2021-2030
FIGURE 12. TOP WINNING STRATEGIES: BY COMPANY, 2021-2030 (%)
FIGURE 13. U.S. PET INDUSTRY EXPENDITURE, 2014-2021($BILLION)
FIGURE 14. IMPACT ANALYSES
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020 & 2030(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY COUNTRY, 2020 & 2030(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY COUNTRY, 2020 & 2030(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER SERVICES, BY COUNTRY, 2020 & 2030(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR DOGS, BY COUNTRY, 2020 & 2030(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CATS, BY COUNTRY, 2020 & 2030(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR DERMATOLOGY, BY COUNTRY, 2020 & 2030(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR GASTROINTESTINAL, BY COUNTRY, 2020 & 2030(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2020 & 2030(%)
FIGURE 24. U.S. VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 25. CANADA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 26. MEXICO VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 27. GERMANY VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 28. FRANCE VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 29. UK VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 30. ITALY VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 31. SPAIN VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 32. REST OF EUROPE VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 33. JAPAN VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 34. CHINA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 35. AUSTRALIA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 36. REST OF ASIA-PACIFIC VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 37. BRAZIL VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 38. SAUDI ARABIA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 39. SOUTH AFRICA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 40. REST OF LAMEA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 41. CHARLES RIVER LABORATORIES INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 42. CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43. CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY REGION, 2020 (%)

Companies Mentioned

  • Charles River Laboratories Inc.
  • Clinvet
  • KLIFOVET AG
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd.
  • VetPharm Inc. and VETSPIN SRL

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...